| P50 | author | Valentín Fuster Carulla | Q977751 |
| | James H Rudd | Q57077698 |
| | Olivier Meilhac | Q57244186 |
| | Jose L Martín-Ventura | Q62131494 |
| | Willem J.M. Mulder | Q62656505 |
| | Didier Letourneur | Q38545565 |
| | Fabien Hyafil | Q41104333 |
| | Ziad Mallat | Q45827826 |
| P2093 | author name string | Jean-Baptiste Michel | |
| | Zahi A Fayad | |
| | Jesus Egido | |
| | Gert Storm | |
| | Francesco Ramirez | |
| | Irene C Turnbull | |
| | Robert Thompson | |
| | Carlos Zaragoza | |
| | Peter Faries | |
| | Ahmed Klink | |
| P2860 | cites work | Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. The UK Small Aneurysm Trial Participants | Q77683215 |
| | The influence of screening on the incidence of ruptured abdominal aortic aneurysms | Q78095836 |
| | Accuracy of serial screening for abdominal aortic aneurysms by ultrasound | Q78346637 |
| | ACE inhibitors and aortic rupture | Q79329495 |
| | Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation | Q80357442 |
| | Presence of NGAL/MMP-9 complexes in human abdominal aortic aneurysms | Q80848315 |
| | Abdominal aortic aneurysm | Q81706496 |
| | Search for serum biomarkers associated with abdominal aortic aneurysm growth--a pilot study | Q83101992 |
| | Biomarkers of abdominal aortic aneurysm progression. Part 2: inflammation | Q84107363 |
| | Ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging of abdominal aortic aneurysms--a feasibility study | Q85091769 |
| | Experimental models for the study of drugs used to prevent and treat vascular diseases | Q95823122 |
| | Screening for abdominal aortic aneurysms: single centre randomised controlled trial | Q24555738 |
| | Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model | Q28571355 |
| | Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin | Q30308172 |
| | Magnetic resonance imaging identifies the fibrous cap in atherosclerotic abdominal aortic aneurysm | Q30312107 |
| | Molecular imaging of cardiovascular disease using ultrasound | Q30461248 |
| | Multidirectional flow analysis by cardiovascular magnetic resonance in aneurysm development following repair of aortic coarctation | Q30482401 |
| | Magnetic resonance molecular imaging of thrombosis in an arachidonic acid mouse model using an activated platelet targeted probe. | Q30494337 |
| | Evaluation of the aortic root by MRI: insights from patients with homozygous familial hypercholesterolemia | Q32035362 |
| | Reducing protein concentration range of biological samples using solid-phase ligand libraries | Q33232993 |
| | Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study | Q33254545 |
| | Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice | Q33399367 |
| | The association between cigarette smoking and abdominal aortic aneurysms | Q33882764 |
| | Influence of screening on the incidence of ruptured abdominal aortic aneurysm: 5-year results of a randomized controlled study | Q34058350 |
| | Recent advances in molecular mechanisms of abdominal aortic aneurysm formation | Q34081328 |
| | Immediate repair compared with surveillance of small abdominal aortic aneurysms | Q34127659 |
| | Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. | Q34132798 |
| | The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial | Q34160045 |
| | Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial | Q34346099 |
| | Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial | Q34428985 |
| | Association Between Osteopontin and Human Abdominal Aortic Aneurysm | Q57253686 |
| | Screening for Abdominal Aortic Aneurysm Reduces Overall Mortality in Men. A Meta-analysis of the Mid- and Long-term Effects of Screening for Abdominal Aortic Aneurysms | Q57446165 |
| | Presence of NGAL/MMP-9 complexes in human abdominal aortic aneurysms | Q57607651 |
| | Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms | Q59315359 |
| | Cytokines as Plasma Markers of Abdominal Aortic Aneurysm | Q60210241 |
| | Aortic Aneurysms in a Rat Model: In Vivo MR Imaging of Endovascular Cell Therapy | Q63944678 |
| | Correlation of inflammatory infiltrate with the enlargement of experimental aortic aneurysms | Q67546301 |
| | Elastase-induced experimental aneurysms in rats | Q68426746 |
| | Effect of beta-adrenergic blockade on the growth rate of abdominal aortic aneurysms | Q69916502 |
| | Modulation by propranolol of the lysyl cross-links in aortic elastin and collagen of the aneurysm-prone turkey | Q70440102 |
| | Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase | Q71093820 |
| | Cell-free arterial grafts: morphologic characteristics of aortic isografts, allografts, and xenografts in rats | Q72289706 |
| | Risk factors associated with rapid growth of small abdominal aortic aneurysms | Q73082652 |
| | Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms | Q73422910 |
| | Feasibility of using dynamic contrast-enhanced magnetic resonance angiography as the sole imaging modality prior to endovascular repair of abdominal aortic aneurysms | Q73827753 |
| | Initial results of ultrasound screening for aneurysm of the abdominal aorta in Western Australia: relevance for endoluminal treatment of aneurysm disease | Q73835604 |
| | Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice | Q74139373 |
| | Contrasting outcomes of atheroma evolution: intimal accumulation versus medial destruction | Q74514963 |
| | Fifteen-year follow-up of a randomized clinical trial of ultrasonographic screening for abdominal aortic aneurysms | Q34579667 |
| | Long-term durability of open abdominal aortic aneurysm repair. | Q34695201 |
| | A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods | Q34962488 |
| | Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus | Q35098414 |
| | Detection, management, and prospects for the medical treatment of small abdominal aortic aneurysms | Q35578689 |
| | Critical role of dipeptidyl peptidase I in neutrophil recruitment during the development of experimental abdominal aortic aneurysms | Q35635554 |
| | Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms | Q35747748 |
| | Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice | Q36025276 |
| | ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascul | Q36426489 |
| | Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue | Q36462801 |
| | Models of abdominal aortic aneurysm: characterization and clinical applications | Q36675621 |
| | Proteomics in atherothrombosis: a future perspective | Q36787244 |
| | Matrix biology of abdominal aortic aneurysms in diabetes: mechanisms underlying the negative association | Q36830867 |
| | Medical management of abdominal aortic aneurysm | Q36836374 |
| | Experimental models of abdominal aortic aneurysms: an overview | Q37090224 |
| | Multimodality nanotracers for cardiovascular applications. | Q37222159 |
| | Lymphoid neogenesis in chronic rejection | Q37228243 |
| | Nanotechnology in medical imaging: probe design and applications. | Q37341362 |
| | The PIVOTAL study: a randomized comparison of endovascular repair versus surveillance in patients with smaller abdominal aortic aneurysms | Q37378779 |
| | Randomized clinical trials of endovascular repair versus surveillance for treatment of small abdominal aortic aneurysms | Q37422472 |
| | An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. | Q37452257 |
| | Biomarkers of AAA progression. Part 1: extracellular matrix degeneration | Q37495418 |
| | Dynamics of the aorta before and after endovascular aneurysm repair: a systematic review | Q37569274 |
| | Interpretation of the results of OVER in the context of EVAR trial, DREAM, and the EUROSTAR registry | Q37786429 |
| | The effect of azithromycin and Chlamydophilia pneumonia infection on expansion of small abdominal aortic aneurysms--a prospective randomized double-blind trial. | Q37854735 |
| | Indicators of infection with Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysms. | Q37873698 |
| | Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution | Q38622747 |
| | In vivo imaging of abdominal aortic aneurysms: increased FDG uptake suggests inflammation in the aneurysm wall | Q40054834 |
| | Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. | Q40600528 |
| | Serum elastin peptides in the preoperative evaluation of abdominal aortic aneurysms. | Q40673084 |
| | Propranolol stimulates the crosslinking of matrix components in skin from the aneurysm-prone blotchy mouse | Q41304330 |
| | Mediators of neutrophil recruitment in human abdominal aortic aneurysms | Q41806974 |
| | TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice | Q41998884 |
| | Long-term cardiovascular outcome after elective abdominal aortic aneurysm open repair | Q42655192 |
| | Endovascular versus open repair of abdominal aortic aneurysm | Q42656213 |
| | Late reintervention for aortic graft-related events and new aortoiliac disease after open abdominal aortic aneurysm repair in an Australian population | Q42683258 |
| | High levels of 18F-FDG uptake in aortic aneurysm wall are associated with high wall stress | Q43238480 |
| | Measurement of abdominal aortic aneurysms with three-dimensional ultrasound imaging: preliminary report | Q43570728 |
| | Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion | Q43697974 |
| | Propranolol for small abdominal aortic aneurysms: results of a randomized trial | Q43861019 |
| | Positron emission tomography (PET) evaluation of abdominal aortic aneurysm (AAA). | Q44003957 |
| | Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice. | Q45204273 |
| | The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators | Q45334593 |
| | Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group | Q45335353 |
| | Involvement of vascular angiotensin II-forming enzymes in the progression of aortic abdominal aneurysms in angiotensin II- infused ApoE-deficient mice. | Q45952330 |
| | Macrophage migration inhibitory factor is associated with aneurysmal expansion | Q46086580 |
| | Differential inflammatory activity across human abdominal aortic aneurysms reveals neutrophil-derived leukotriene B4 as a major chemotactic factor released from the intraluminal thrombus. | Q46167717 |
| | Growth predictors and prognosis of small abdominal aortic aneurysms | Q46597243 |
| | Preoperative thrombus volume predicts sac regression after endovascular aneurysm repair | Q46685585 |
| | Inhibition of macrophage phagocytotic activity by a receptor-targeted polymer vesicle-based drug delivery formulation of pravastatin | Q46689999 |
| | Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase | Q46823363 |
| | Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins | Q46915816 |
| | Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth | Q46977744 |
| | Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade | Q47377735 |
| | Growth rates and risk of rupture of abdominal aortic aneurysms | Q50151397 |
| | Five-year results of elastin and collagen markers as predictive tools in the management of small abdominal aortic aneurysms. | Q50674698 |
| | Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. | Q50745596 |
| | Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. | Q50917495 |
| | Aortic compliance following EVAR and the influence of different endografts: determination using dynamic MRA. | Q51177305 |
| | Preliminary ten year results from a randomised single centre mass screening trial for abdominal aortic aneurysm. | Q51492930 |
| | The validity of ultrasonographic scanning as screening method for abdominal aortic aneurysm. | Q51562775 |
| | Rapid assessment of abdominal aortic aneurysms by 3-dimensional ultrasonography. | Q51924462 |
| | Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. | Q52037368 |
| | Learning from the last ultrasound. A population-based study of patients with abdominal aortic aneurysm. | Q52192437 |
| | Limitations of ultrasonography in surveillance of small abdominal aortic aneurysms. | Q52864639 |
| | Quality of the measurement of the infrarenal aortic diameter by ultrasound. | Q52895392 |
| | Bleeding into the intraluminal thrombus in abdominal aortic aneurysms is associated with rupture. | Q53395825 |
| | Delayed enhancement on computed tomography in abdominal aortic aneurysm wall. | Q53491973 |
| | Time-resolved 3D MR velocity mapping at 3T: improved navigator-gated assessment of vascular anatomy and blood flow. | Q53495917 |
| | Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms | Q54214079 |
| | Long-Term Outcome of Open or Endovascular Repair of Abdominal Aortic Aneurysm | Q56603413 |
| | Simvastatin Attenuates the Activity of Matrix Metalloprotease-9 in Aneurysmal Aortic Tissue | Q56891338 |
| | Long-Term Outcomes of Immediate Repair Compared with Surveillance of Small Abdominal Aortic Aneurysms | Q56891514 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diagnosis | Q16644043 |
| P304 | page(s) | 338-347 | |
| P577 | publication date | 2011-02-08 | |
| P1433 | published in | Nature Reviews Cardiology | Q2108444 |
| P1476 | title | Diagnostic and therapeutic strategies for small abdominal aortic aneurysms | |
| P478 | volume | 8 | |